Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 49100, Israel.
Mayo Clin Proc. 2011 May;86(5):389-96. doi: 10.4065/mcp.2010.0705.
To identify risk factors and outcomes associated with thrombocytopenia at sepsis onset in Staphylococcus aureus bacteremia.
This single-center, retrospective, cohort study consists of all adult patients with a first episode of clinical S aureus bacteremia between April 1, 1988, and September 30, 1994, and between January 1, 1999, and December 31, 2007. Thrombocytopenia was defined as a platelet count less than 150 × 10(9)/L. The primary outcome was 30-day all-cause mortality. Risk factors for 30-day all-cause mortality were identified using univariate and multivariable analyses. Multivariable analysis was conducted using forward step logistic regression analysis. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for risk of death.
A total of 1052 patients had clinical S aureus bacteremia. Thrombocytopenia at sepsis onset was present in 235 patients (22.3%). Thrombocytopenia was associated with community-acquired bacteremia, infections caused by methicillin-sensitive S aureus, high-magnitude bacteremia (defined as >4 positive blood cultures [≥ 3 separate positive blood culture sets]), and endocarditis. Patients with thrombocytopenia presented more commonly with severe sepsis reflected by septic shock and acute renal failure. Thirty-day mortality was significantly higher among patients with thrombocytopenia (132/235 [56.2%]) vs those without thrombocytopenia (281/817 [34.4%]; P<.001). Higher mortality was associated with the degree of thrombocytopenia. In multivariable analysis, thrombocytopenia at baseline remained an independent risk factor for 30-day mortality (OR, 2.82; 95% CI, 1.87-4.24). The adjusted association between thrombocytopenia and death remained similar among the 917 patients with monomicrobial bacteremia (OR, 2.88; 95% CI, 1.83-4.53) and the 945 patients who did not die within the first 48 hours (OR, 2.88; 95% CI, 1.87-4.45.).
We observed a strong association between thrombocytopenia at sepsis onset and all-cause mortality in S aureus bacteremia, possibly related to mechanisms other than sepsis alone.
确定金黄色葡萄球菌菌血症发病时血小板减少与败血症相关的风险因素和结局。
这是一项单中心、回顾性队列研究,纳入了 1988 年 4 月 1 日至 1994 年 9 月 30 日和 1999 年 1 月 1 日至 2007 年 12 月 31 日期间首次出现临床金黄色葡萄球菌菌血症的所有成年患者。血小板减少定义为血小板计数<150×109/L。主要结局为 30 天全因死亡率。使用单因素和多因素分析确定 30 天全因死亡率的风险因素。多变量分析采用逐步向前逻辑回归分析进行。计算死亡风险的比值比(OR)及其 95%置信区间(CI)。
共有 1052 例患者患有临床金黄色葡萄球菌菌血症。发病时血小板减少 235 例(22.3%)。血小板减少与社区获得性菌血症、耐甲氧西林金黄色葡萄球菌引起的感染、高菌血症(定义为>4 份阳性血培养[≥3 份独立阳性血培养集])和心内膜炎有关。血小板减少症患者更常见于伴有感染性休克和急性肾衰竭的严重败血症。血小板减少症患者的 30 天死亡率明显更高(235 例中有 132 例[56.2%]),而非血小板减少症患者(817 例中有 281 例[34.4%];P<.001)。血小板减少症的严重程度与死亡率较高有关。多变量分析显示,发病时血小板减少仍是 30 天死亡率的独立危险因素(OR,2.82;95%CI,1.87-4.24)。血小板减少症与死亡之间的调整关联在 917 例单一微生物菌血症患者(OR,2.88;95%CI,1.83-4.53)和 945 例在 48 小时内未死亡的患者(OR,2.88;95%CI,1.87-4.45)中仍相似。
我们观察到金黄色葡萄球菌菌血症发病时血小板减少与全因死亡率之间存在很强的关联,这可能与败血症以外的机制有关。